AAPL 221.875 -3.5242% MSFT 427.22 -0.4219% NVDA 139.85 1.554% GOOGL 199.3225 1.6952% GOOG 201.35 1.9236% AMZN 228.7043 1.2235% META 617.385 0.7531% AVGO 239.5299 0.8802% TSLA 413.825 -2.9719% TSM 213.7392 1.0587% LLY 735.7301 1.3793% V 322.15 0.7916% JPM 261.25 0.8065% UNH 520.02 2.0127% NVO 80.28 2.0206% WMT 93.245 1.4194% LVMUY 145.13 2.1467% XOM 111.61 -0.6321% LVMHF 725.1 1.976% MA 529.315 0.8796%
AAPL 221.875 -3.5242% MSFT 427.22 -0.4219% NVDA 139.85 1.554% GOOGL 199.3225 1.6952% GOOG 201.35 1.9236% AMZN 228.7043 1.2235% META 617.385 0.7531% AVGO 239.5299 0.8802% TSLA 413.825 -2.9719% TSM 213.7392 1.0587% LLY 735.7301 1.3793% V 322.15 0.7916% JPM 261.25 0.8065% UNH 520.02 2.0127% NVO 80.28 2.0206% WMT 93.245 1.4194% LVMUY 145.13 2.1467% XOM 111.61 -0.6321% LVMHF 725.1 1.976% MA 529.315 0.8796%

Nutex Health Inc

Healthcare US NUTX

38.87USD
1.06(2.80%)

Last update at 2025-01-21T14:30:00Z

Day Range

38.8738.87
LowHigh

52 Week Range

0.508.25
LowHigh

Fundamentals

  • Previous Close 37.81
  • Market Cap34.88M
  • Volume901
  • P/E Ratio1.25
  • Dividend Yield-%
  • EBITDA12.38M
  • Revenue TTM258.77M
  • Revenue Per Share TTM5.71
  • Gross Profit TTM 36.30M
  • Diluted EPS TTM0.56

Financials

Income Statement

2018-12-312019-12-312020-12-312021-12-312022-12-31-400M-300M-200M-100M0M100M200M300M
Total Revenue
Net Income

Balancesheet

2019-12-312020-12-312021-12-312022-12-312023-12-310M50M100M150M200M250M300M350M400M
Total Assets
Total Liabilities

Change in Cash

2019-12-312020-12-312021-12-312022-12-312023-12-31-12M-10M-8M-6M-4M-2M0M2M4M6M8M10M12M14M16M

Total Operating Cash

2019-12-312020-12-312021-12-312022-12-312023-12-310M20M40M60M80M100M120M140M160M180M

Dividends Paid

2019-12-312020-12-312021-12-312022-12-312023-12-310M20M40M60M80M100M120M140M
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax -419.64871M 169.49M 145.56M 32.09M -2.81425M
Minority interest -7.95917M -35.93196M -44.74198M -11.16623M -
Net income -432.73962M 132.59M 100.82M 16.48M -2.81425M
Selling general administrative 18.03M 5.46M 115.13M 59.87M 1.16M
Selling and marketing expenses - 0.02M 0.17M 0.58M -
Gross profit 13.45M 179.28M 271.60M 95.40M 0.03M
Reconciled depreciation 13.13M 7.66M 5.96M 2.48M -
Ebit -5.13775M 170.26M 152.33M 34.71M -
Ebitda 7.99M 186.90M 157.95M 38.10M -1.83056M
Depreciation and amortization 13.13M 16.64M 5.62M 3.39M -
Non operating income net other -0.55930M - - - -
Operating income -5.13775M 170.26M 152.33M 34.71M -1.83056M
Other operating expenses 223.87M 157.71M 121.09M 62.35M 1.86M
Interest expense 12.49M 6.20M 6.43M 3.53M 0.64M
Tax provision 13.09M 0.97M - - -
Interest income - - - - -
Net interest income -12.49026M -6.19603M -6.43294M -3.53052M -
Extraordinary items - - - - -
Non recurring 402.02M - - - -
Other items - - - - -
Income tax expense 13.09M 0.97M 50.83M 15.61M -
Total revenue 219.29M 331.53M 273.42M 97.06M 0.09M
Total operating expenses 18.03M 5.46M 121.09M 62.35M 1.80M
Cost of revenue 205.84M 152.25M 1.82M 1.66M 0.06M
Total other income expense net -414.51096M -0.77388M -6.77505M -2.62136M -0.98368M
Discontinued operations - - - - -
Net income from continuing ops -432.73962M 168.53M 145.56M 32.09M -
Net income applicable to common shares -424.78045M 132.59M 100.82M 20.92M -
Preferred stock and other adjustments - - - - -
Breakdown 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly yearly
Date 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Total assets 398.25M 431.75M 394.65M 308.55M 179.22M
Intangible assets 20.51M 21.19M 0.68M - 1.54M
Earning assets - - - - -
Other current assets 2.68M 1.87M 0.32M 0.13M 0.70M
Total liab 319.14M 311.42M 203.07M 161.19M 128.39M
Total stockholder equity 61.45M 95.86M 114.65M 85.81M 28.31M
Deferred long term liab - - - - -
Other current liab 12.96M 6.24M 6.86M 2.40M 3.00M
Common stock 0.68M 0.65M 0.59M 0.00528M 0.00465M
Capital stock 0.68M 0.65M 0.59M - -
Retained earnings -409.07254M -363.28593M 102.32M -18.21896M -12.56879M
Other liab - 10.45M - - -
Good will 17.07M 17.01M 1.14M 1.14M 1.14M
Other assets - 0.42M 0.46M 1.10M -0.00000M
Cash 22.00M 34.26M 36.12M 25.51M 8.00M
Cash and equivalents - - - - -
Total current liabilities 58.31M 54.86M 37.69M 31.45M 72.13M
Current deferred revenue - - - 0.04M 0.17M
Net debt 253.75M 232.95M 142.43M 124.61M 111.94M
Short term debt 20.08M 21.09M 13.17M 20.39M 63.68M
Short long term debt 14.18M 15.17M 10.23M 18.65M 13.35M
Short long term debt total 275.76M 267.20M 178.55M 150.12M 119.94M
Other stockholder equity 469.85M 458.50M 11.74M 104.02M 40.87M
Property plant equipment - 82.09M 238.36M 170.81M 131.28M
Total current assets 90.85M 97.97M 154.02M 135.51M 45.74M
Long term investments - - - - -
Net tangible assets - 57.66M 112.83M 84.67M 27.17M
Short term investments - - - - -
Net receivables 62.78M 58.32M 114.76M 108.14M 36.14M
Long term debt 26.31M 23.05M 78.82M 81.90M 40.88M
Inventory 3.39M 3.53M 2.81M 1.73M 0.90M
Accounts payable 25.28M 27.53M 17.65M 8.63M 5.29M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - 24.46M - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - - - - -
Additional paid in capital - - - - -
Common stock total equity - 0.65M - - -
Preferred stock total equity - - - - -
Retained earnings total equity - -363.28593M - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 0.43M 0.42M 0.46M 1.10M 1.06M
Deferred long term asset charges - - - - -
Non current assets total 307.40M 333.78M 240.63M 173.05M 133.48M
Capital lease obligations 235.26M 228.98M 89.50M 49.57M 65.71M
Long term debt total - - - - -
Breakdown 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly yearly
Date 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Investments -4.22543M -4.33740M -36.97544M -61.19192M -31.23411M
Change to liabilities - 8.38M 6.27M 2.58M 1.63M
Total cashflows from investing activities - -4.33740M -36.97544M -61.19192M -31.23411M
Net borrowings - -5.59101M -3.22101M 46.46M 35.57M
Total cash from financing activities -2.26978M -48.13273M -125.85303M -2.56232M 21.71M
Change to operating activities - -2.73100M 4.20M -0.19355M 1.75M
Net income -45.78661M -432.73962M 168.53M 145.56M 32.09M
Change in cash -12.25321M -1.86302M 10.60M 17.51M 2.60M
Begin period cash flow 34.26M 36.12M 25.51M 8.00M 5.40M
End period cash flow 22.00M 34.26M 36.12M 25.51M 8.00M
Total cash from operating activities 1.26M 50.61M 173.43M 81.26M 12.12M
Issuance of capital stock - - - - -
Depreciation 17.59M 13.13M 7.66M 5.96M 2.48M
Other cashflows from investing activities - 12.72M - - -
Dividends paid 5.21M 51.23M 144.34M 59.05M 18.90M
Change to inventory 0.14M -0.71911M -1.08849M -0.82577M -0.48627M
Change to account receivables -4.58365M 58.08M -6.62255M -71.23471M -24.74258M
Sale purchase of stock - 4.76M - -0.12000M -4.11250M
Other cashflows from financing activities -4.91655M 8.01M 41.32M 71.85M 46.54M
Change to netincome - 403.32M 30.37M 44.16M 10.57M
Capital expenditures 9.50M 14.63M 36.93M 61.19M 32.28M
Change receivables - 58.08M - - -
Cash flows other operating - -0.79334M - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - -1.86302M - - -
Change in working capital -1.66133M 64.32M 2.75M -69.67375M -21.84535M
Stock based compensation 2.84M 0.19M 10.34M 2.57M 0.45M
Other non cash items 33.98M 400.71M -5.50824M -0.58064M -0.59694M
Free cash flow -8.24038M 35.97M 136.51M 20.07M -20.15069M

Peer Comparison

Sector: Healthcare Industry: Health Information Services

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
NUTX
Nutex Health Inc
1.06 2.80% 38.87 1.25 - 0.13 0.54 1.16 -19.6892
GEHC
GE HealthCare Technologies Inc.
1.31 1.55% 86.05 22.91 20.12 2.01 5.52 2.39 13.30
VEEV
Veeva Systems Inc Class A
1.86 0.86% 218.46 54.61 33.22 12.83 6.73 11.14 58.84
MTHRF
M3 Inc
- -% 8.33 29.72 25.00 0.05 4.38 0.04 0.12
MTHRY
M3 Inc
-0.09 1.97% 4.47 31.84 26.25 0.05 4.60 0.04 0.12

Reports Covered

Stock Research & News

Profile

Nutex Health Inc. operates as a physician-led, healthcare services, and operations company. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The PHM segment establishes and operates independent physician associations; and offers a cloud-based platform for healthcare organizations to provide value-based care and population health management. The Real Estate segment owns and owns and leases land and hospital building. The Hospital segment develops and operates a network of micro-hospitals, specialty hospitals and hospital outpatient departments which offers 24/7 care. It also provides operational and managerial services, including management, billing, collections, human resources and recruiting, legal, accounting, and marketing. In addition, the company offers healthcare services, including emergency room care, inpatient care, and behavioral health, as well as onsite imaging, such as CT scan, X-ray, MRI, ultrasound, etc.; certified and accredited laboratories; and onsite inpatient pharmacies. The company was founded in 2011 and is based in Houston, Texas.

Nutex Health Inc

6030 South Rice Avenue, Houston, TX, United States, 77081

Key Executives

Name Title Year Born
Dr. Thomas T. Vo M.B.A., M.D. Chairman & CEO NA
Dr. Warren Hosseinion M.D. Pres & Director 1972
Mr. Jon C. Bates Chief Financial Officer 1970
Ms. Denise Pufal Director of Operations NA
Ms. LaChoenda Rosales Director of Accounting NA
Ms. Pamela W. Montgomery B.S.N., J.D., L.L.M., M.S.N., R.N. Chief Legal Officer & Board Sec. NA
Ms. Vivian Sanders M.B.A. Director of Marketing NA
Elizabeth Hall HR Mang. NA
Sarah Wallace Director of HR NA
Dr. Lawrence Schimmel F.A.C.S. Chief Medical Information Officer 1949

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.